Spironolactone Ceva

RSS

Withdrawn

This medicine's authorisation has been withdrawn

spironolactone
MedicineVeterinaryWithdrawn

Danish is available via eTranslation, the European Commission's machine translation service.

Translate to Danish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn due to the application of the sunset clause.

български (BG) (332.91 KB - PDF)

Vis

español (ES) (288.28 KB - PDF)

Vis

čeština (CS) (322.23 KB - PDF)

Vis

dansk (DA) (287.53 KB - PDF)

Vis

Deutsch (DE) (289.53 KB - PDF)

Vis

eesti (ET) (276.29 KB - PDF)

Vis

ελληνικά (EL) (335.21 KB - PDF)

Vis

français (FR) (289.25 KB - PDF)

Vis

hrvatski (HR) (307.68 KB - PDF)

Vis

latviešu (LV) (334.28 KB - PDF)

Vis

Malti (MT) (324.47 KB - PDF)

Vis

Nederlands (NL) (287.82 KB - PDF)

Vis

polski (PL) (380.69 KB - PDF)

Vis

português (PT) (288.12 KB - PDF)

Vis

română (RO) (482.45 KB - PDF)

Vis

slovenčina (SK) (324.97 KB - PDF)

Vis

slovenščina (SL) (318.42 KB - PDF)

Vis

suomi (FI) (285.73 KB - PDF)

Vis

svenska (SV) (287.15 KB - PDF)

Vis

Product information

български (BG) (936.84 KB - PDF)

Vis

español (ES) (457.64 KB - PDF)

Vis

čeština (CS) (695.23 KB - PDF)

Vis

dansk (DA) (443.55 KB - PDF)

Vis

Deutsch (DE) (456.17 KB - PDF)

Vis

eesti (ET) (460.88 KB - PDF)

Vis

ελληνικά (EL) (957.24 KB - PDF)

Vis

français (FR) (383.63 KB - PDF)

Vis

hrvatski (HR) (504.46 KB - PDF)

Vis

italiano (IT) (614.01 KB - PDF)

Vis

latviešu (LV) (750.12 KB - PDF)

Vis

lietuvių (LT) (673.01 KB - PDF)

Vis

magyar (HU) (1.07 MB - PDF)

Vis

Malti (MT) (774.79 KB - PDF)

Vis

Nederlands (NL) (445.92 KB - PDF)

Vis

polski (PL) (1.09 MB - PDF)

Vis

português (PT) (456.69 KB - PDF)

Vis

română (RO) (807.04 KB - PDF)

Vis

slovenčina (SK) (711.68 KB - PDF)

Vis

slovenščina (SL) (702.28 KB - PDF)

Vis

suomi (FI) (456.54 KB - PDF)

Vis

svenska (SV) (441.7 KB - PDF)

Vis

Íslenska (IS) (622.5 KB - PDF)

Vis

norsk (NO) (656.3 KB - PDF)

Vis
Latest procedure affecting product information:IAIN/0014
31/10/2012

български (BG) (299.51 KB - PDF)

Vis

español (ES) (219.22 KB - PDF)

Vis

čeština (CS) (262.67 KB - PDF)

Vis

dansk (DA) (227.42 KB - PDF)

Vis

Deutsch (DE) (218.75 KB - PDF)

Vis

eesti (ET) (221.16 KB - PDF)

Vis

ελληνικά (EL) (268.37 KB - PDF)

Vis

français (FR) (221.14 KB - PDF)

Vis

hrvatski (HR) (227.55 KB - PDF)

Vis

italiano (IT) (191.92 KB - PDF)

Vis

latviešu (LV) (256.74 KB - PDF)

Vis

lietuvių (LT) (210.34 KB - PDF)

Vis

magyar (HU) (210.45 KB - PDF)

Vis

Malti (MT) (250.85 KB - PDF)

Vis

Nederlands (NL) (228.06 KB - PDF)

Vis

polski (PL) (245.92 KB - PDF)

Vis

português (PT) (231.37 KB - PDF)

Vis

română (RO) (434.62 KB - PDF)

Vis

slovenčina (SK) (253.67 KB - PDF)

Vis

slovenščina (SL) (237.31 KB - PDF)

Vis

suomi (FI) (204.11 KB - PDF)

Vis

svenska (SV) (218.51 KB - PDF)

Vis

Íslenska (IS) (185.95 KB - PDF)

Vis

norsk (NO) (222.67 KB - PDF)

Vis

Product details

Name of medicine
Spironolactone Ceva
Active substance
spironolactone
International non-proprietary name (INN) or common name
spironolactone
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QC03DA01

Pharmacotherapeutic group

Diuretics

Therapeutic indication

For use in combination with standard therapy (including diuretic support, where necessary) for the treatment of congestive heart failure caused by valvular regurgitation in dogs.

Authorisation details

EMA product number
EMEA/V/C/000105
Marketing authorisation holder
Ceva Santé Animale

10 avenue de la Ballastière
33500 Libourne
France

Opinion adopted
17/04/2007
Marketing authorisation issued
20/06/2007
Revision
7

Assessment history

This page was last updated on

Share this page